Andrew Dudum

Andrew Dudum is a Palestinian-American entrepreneur who is the founder and CEO of telehealth startup Hims & Hers Health, Inc.

Dudum was born and raised in San Francisco, California. He is an American of Palestinian heritage. He trained as a classical cellist and performed live across the United States and Europe, at hundreds of concerts and weddings, including at Carnegie Hall.^[1] He attended the Wharton School of the University of Pennsylvania, where he studied Management and Economics. Dudum did not finish his degree and is therefore a college dropout.^[2]

While in college, Dudum co-founded LendforPeace, a nonprofit microlending site for Middle Eastern entrepreneurs. He later worked at TokBox, a video-chat startup that was eventually acquired.^[1] The acquisition of TokBox freed Dudum up to pursue his goal to build a startup. In 2013, Dudum co-founded Atomic Labs, a San Francisco-based startup studio backed by investors such as Peter Thiel and Marc Andreessen. Atomic launched companies including Bungalow, Homebound, TalkIQ, and Terminal.^[2][3] In 2016, Dudum founded Hims, a direct-to-consumer telehealth startup, still as part of Atomic. He has served as CEO since its inception.^[2] The company expanded into women's health under the brand Hims & Hers, offering online consultations, prescriptions, and over-the-counter products.^[4] Hims raised over US$100 million in funding and became a “unicorn” in 2019. In 2020, Hims went public via a SPAC at a $1.6 billion valuation, debuting on the New York Stock Exchange in January 2021 under the ticker NYSE: HIMS.^[5] In 2024, Hims & Hers expanded into GLP-1 weight loss medicine and generated annual revenues of $1.48 billion.^[6][7][8] Andrew Dudum has a net worth of approximately $1 billion.^[9][10]

In 2024, Dudum drew both praise and some criticism for a social media post in which he encouraged companies to hire student protesters involved in anti-Israel demonstrations. He later clarified his statement as support for peaceful protest and free speech.^[1][11]

In 2025, his San Francisco donut shop, George's Donuts & Merriment, drew local backlash after a $1 million Hims & Hers donation to President Donald Trump's inaugural committee became public.^[12]

In mid-2025, Hims & Hers Health faced increased scrutiny after its partnership with Novo Nordisk ended, with both companies citing differing views on compounded GLP-1 weight-loss drugs. Reuters and Bloomberg reported that despite the termination, Hims continued its expansion and reaffirmed annual guidance.^[13][14]

• Hims & Hers Health